Skip Navigation



ToxSci Advance Access published online on August 18, 2008

Toxicological Sciences, doi:10.1093/toxsci/kfn166
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
106/1/162    most recent
kfn166v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wolf, C. J.
Right arrow Articles by Abbott, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolf, C. J.
Right arrow Articles by Abbott, B. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2008

Activation of mouse and human peroxisome proliferator-activated receptor alpha (PPAR{alpha}) by perfluoroalkyl acids (PFAAs) of different functional groups and chain lengths

Cynthia J. Wolf, Margy L. Takacs, Judith E. Schmid, Christopher Lau and Barbara D. Abbott

Reproductive Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, NC 27711

Address correspondence to: Cynthia J. Wolf, US Environmental Protection Agency, Office of Research and Development, National Health and Environmental Effects Reasearch Laboratory, Reproductive Toxicology Division, MD-67, Reasearch Triangle Park, NC 27711

Received May 22, 2008; revision received July 16, 2008; accepted August 6, 2008


   Abstract

Perfluoroalkyl acids (PFAAs) are surfactants used in consumer products and persist in the environment. Some PFAAs elicit adverse effects on rodent development and survival. PFAAs can activate PPAR{alpha} and may act via PPAR{alpha} to produce some of their effects. This study evaluated the ability of numerous PFAAs to induce mouse and human PPAR{alpha} activity in a transiently transfected COS-1 cell assay. COS-1 cells were transfected with either a mouse or human PPAR{alpha} receptor-luciferase reporter plasmid. After 24 hours, cells were exposed to either negative controls (water or DMSO, 0.1%), positive control (WY-14,643, PPAR{alpha} agonist); perfluorooctanoic acid (PFOA) or perfluorononanoic acid (PFNA) at 0.5-100 µM; perfluorobutanoic acid (PFBA), perfluorohexanoic acid (PFHxA), perfluorohexane sulfonate (PFHxS), or perfluorodecanoic acid (PFDA) at 5-100 µM; or perfluorobutane sulfonate (PFBS) or perfluorooctane sulfonate (PFOS) at 1-250 µM. After 24 hrs of exposure, luciferase activity from the plasmid was measured. Each PFAA activated both mouse and human PPAR{alpha} in a concentration-dependent fashion, except PFDA with human PPAR{alpha}. Activation of PPAR{alpha} by PFAA carboxylates was positively correlated with carbon chain length, up to C9. PPAR{alpha} activity was higher in response to carboxylates compared to sulfonates. Activation of mouse PPAR{alpha} was generally higher compared to that of human PPAR{alpha}. We conclude that, in general, (i) PFAAs of increasing carbon backbone chain lengths induce increasing activity of the mouse and human PPAR{alpha} with a few exceptions, (ii) PFAA carboxylates are stronger activators of mouse and human PPAR{alpha} than PFAA sulfonates, and (iii) in most cases, the mouse PPAR{alpha} appears to be more sensitive to PFAAs than the human PPAR{alpha} in this model.

Key Words: perfluoroalkyl acids; PFAA; peroxisome proliferator activated receptor-alpha; PPAR{alpha}; PFOS; PFOA; PFNA; PFBA; transient transfection assay; COS-1 cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
N. J. Hickey, D. Crump, S. P. Jones, and S. W. Kennedy
Effects of 18 Perfluoroalkyl Compounds on mRNA Expression in Chicken Embryo Hepatocyte Cultures
Toxicol. Sci., October 1, 2009; 111(2): 311 - 320.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. B. Rosen, C. Lau, and J. C. Corton
Does Exposure to Perfluoroalkyl Acids Present a Risk to Human Health?
Toxicol. Sci., September 1, 2009; 111(1): 1 - 3.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. A. Bjork and K. B. Wallace
Structure-Activity Relationships and Human Relevance for Perfluoroalkyl Acid-Induced Transcriptional Activation of Peroxisome Proliferation in Liver Cell Cultures
Toxicol. Sci., September 1, 2009; 111(1): 89 - 99.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. E. Foreman, S.-C. Chang, D. J. Ehresman, J. L. Butenhoff, C. R. Anderson, P. S. Palkar, B.-H. Kang, F. J. Gonzalez, and J. M. Peters
Differential Hepatic Effects of Perfluorobutyrate Mediated by Mouse and Human PPAR-{alpha}
Toxicol. Sci., July 1, 2009; 110(1): 204 - 211.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.